Blog


Endo International Settles Securities Settlement for $82.5 Million

Second Endo Settlement of 2019



Endo International... Sound familiar? Earlier this August we posted a blog with a similar title “Endo International Settles Securities Settlement for $50 Million.”

So what’s the difference? Aside from $32.5 million.

The first settlement pertained to declining demand for Endo’s generic drugs and also alleged that Endo had conspired to fix prices, which resulted in inflated stock and later a law enforcement inquiry. Once the scheme collapsed, plaintiffs alleged, the stock price collapsed with it.

This newer settlement pertains to Endo’s role in the opioid crisis. Specifically, plaintiffs allege that “failed to disclose material adverse facts regarding the putative safety and abuse-deterrent properties of Reformulated Opana, an opioid analgesic indicated for the management of severe pain that requires daily opioid treatment.”

Here are the other key facts:

Case name: Endo International

Settlement fund: $82,500,000

Claim filing deadline: 2/7/2020

Class period: 11/30/2012 – 6/8/2017

Definition of class from settlement notice:

“All persons and entities who purchased or otherwise acquired Endo common stock or ordinary shares between November 30, 2012 and June 8, 2017, inclusive, and were damaged thereby.”

Fairness Hearing: 12/11/2019

Exclusion Deadline: 11/22/2019

Objection Deadline: 11/22/2019

How Chicago Clearing Can Help: Every day, our team files claims in a wide assortment of financial class action litigations. We are preparing claims now for potential Endo International Class members… in both settlements! If you or your clients are eligible for this litigation, or any of the other 35 settlements with upcoming deadlines, then please give us a call at 312-204-6970.


More News from the Class Action World



Quick facts about this settlement

Case name: Snap, Inc.

Settlement fund: $187.5 Million

Claim filing deadline: TBD

Class period: March 2, 2017 to August 10, 2017

Settlement notice packets will soon be hitting investors' mailboxes and inboxes for the $187.5 million Snap securities litigation.... Read More

Read More

Quick facts about this settlement

Read More

This week the first securities litigations to spring from the coronavirus crisis have arrived. It's of course expected that an event that has a negative impact on a stock price might soon produce a securities litigation. In recent years, nearly 10% of publicly traded companies are the targets of securities class action complaints each year. Even... Read More

Did you trade debt securities of government sponsored enterprises (aka GSE bonds) between 2009 and 2019? If so, you may be eligible to participate in an antitrust settlement.

Plaintiffs allege that the defendants (see full list below) conspired to fix prices of unsecured GSE bonds issued by Federal National Mortga... Read More

Settlement Fund: $149 Million

Class Period: 2/25/2016 – 9/15/2017

Class Description: all persons and entities who purchased or otherwise acquired publicly-traded Equifax common stock during the... Read More